Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP445920.RAvNc9a4ZeFeGL2cPkAbtyf5Er07UdF2ORKCbzHsE0TZc130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP445920.RAvNc9a4ZeFeGL2cPkAbtyf5Er07UdF2ORKCbzHsE0TZc130_provenance.
• NP673464.RAQW3lz6iqJKrL3TXJLAajQq1lsKKj6v9j97UDpnYE8xM130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673464.RAQW3lz6iqJKrL3TXJLAajQq1lsKKj6v9j97UDpnYE8xM130_provenance.
• assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP276812.RAR8cGRMYjfKaMMpRUcJtZzGfRt5_F6PipSe-PoUTH_Zc130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276812.RAR8cGRMYjfKaMMpRUcJtZzGfRt5_F6PipSe-PoUTH_Zc130_provenance.
• NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_provenance.
• NP879117.RA1zyiQMUCBuGIpC5vVAgwO1aRyKpp3SEqiQViQFNJYlI130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879117.RA1zyiQMUCBuGIpC5vVAgwO1aRyKpp3SEqiQViQFNJYlI130_provenance.
• NP331229.RABfLM80Yq-jHvO18sbjogFSqGSjIkl1JE-EUJVkiI52A130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331229.RABfLM80Yq-jHvO18sbjogFSqGSjIkl1JE-EUJVkiI52A130_provenance.
• NP276781.RAqCx-JL11C18wJeptXZWCmml6X70xPt6JtIVY-KIN1yU130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276781.RAqCx-JL11C18wJeptXZWCmml6X70xPt6JtIVY-KIN1yU130_provenance.
• NP331366.RAx8MsHaQr9C05ELTvEAEw9EnMqYqCkEd0kEWBREwjjkc130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331366.RAx8MsHaQr9C05ELTvEAEw9EnMqYqCkEd0kEWBREwjjkc130_provenance.
• NP335146.RAHkDGgwWz2pYEZP612-i7hnkdFv9R9oKG4-CTDw9w_fY130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335146.RAHkDGgwWz2pYEZP612-i7hnkdFv9R9oKG4-CTDw9w_fY130_provenance.
• NP335147.RAHNwTLr-ZsH-Ahk00tW0UHqwrujXpGBlLx07Vxl98yyQ130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335147.RAHNwTLr-ZsH-Ahk00tW0UHqwrujXpGBlLx07Vxl98yyQ130_provenance.
• NP335148.RAJ1RiipB_bMf7fdiuKg0K2JI3mh55NLkD44RciQ13M3E130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335148.RAJ1RiipB_bMf7fdiuKg0K2JI3mh55NLkD44RciQ13M3E130_provenance.
• NP335152.RAMFLiZC09aSwZ6FvY7-KI-M2triO-4qkrdhCqgbiROLE130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335152.RAMFLiZC09aSwZ6FvY7-KI-M2triO-4qkrdhCqgbiROLE130_provenance.